RNF11 (RING Finger Protein 11) is a small RING-type E3 ubiquitin ligase that functions as a critical regulator of NF-kB signaling and other cellular pathways[1]. It is expressed in various tissues, including the brain, and plays important roles in immune response and cell survival. As a modular signaling protein, RNF11 contains multiple functional domains that enable it to interact with various signaling complexes and regulate diverse cellular processes[2].
The human RNF11 gene encodes a 154-amino acid protein with a C3HC4 RING finger domain at its C-terminus, flanked by proline-rich regions and potential phosphorylation sites. This structure allows RNF11 to serve as a molecular scaffold, bringing together different signaling components and modulating their activity through ubiquitination[3].
RNF11 is a modular signaling protein with multiple functional domains that enable it to participate in various cellular processes:
RNF11 contains a functional RING finger domain that catalyzes ubiquitin transfer to target proteins[4]. This enzymatic activity is essential for:
The E3 ligase activity of RNF11 is regulated by multiple factors including phosphorylation state, protein interactions, and cellular context. Studies have shown that RNF11 can both activate and inhibit ubiquitination depending on the specific target and cellular conditions[5].
RNF11 functions as both a positive and negative regulator of NF-kB signaling depending on context[6]. This dual regulatory function is mediated through:
The balance between RNF11's positive and negative effects on NF-kB signaling is crucial for maintaining proper immune responses. Dysregulation of this balance has been implicated in various pathological conditions including chronic inflammation and neurodegeneration[7].
Beyond NF-kB, RNF11 modulates ERK and JNK MAPK pathways[2:1]. These pathways are critical for:
RNF11's modulation of MAPK signaling involves interactions with MAP3K1 and other upstream kinases, creating a complex network of regulatory interactions that influence cellular outcomes.
RNF11 is a key modulator of neuroinflammatory processes that underlie many neurodegenerative diseases[8]. The protein's role in neuroinflammation encompasses multiple aspects:
Microglia are the resident immune cells of the central nervous system and play a central role in neurodegeneration[9]. RNF11 regulates NF-kB-dependent inflammatory cytokine production in microglia, including:
Microglial activation in response to pathological stimuli leads to a sustained inflammatory response that exacerbates neurodegeneration. RNF11's regulation of this process makes it a potential therapeutic target for modulating neuroinflammation[10].
RNF11 modulates TNF receptor signaling cascades through direct interactions with TNFR-associated signaling complexes[11]. This modulation affects:
The deregulation of cytokine signaling contributes to the chronic neuroinflammation observed in Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative conditions.
In Alzheimer's disease, RNF11 contributes to pathogenesis through multiple mechanisms[12]:
RNF11 influences amyloid precursor protein (APP) trafficking and processing through its effects on cellular trafficking pathways. The ubiquitin-proteasome system plays a crucial role in regulating APP metabolism, and RNF11's E3 ligase activity can affect:
Through its interactions with the ubiquitin system, RNF11 may influence tau protein clearance and aggregation[13]. The UPS is critical for removing abnormal tau species, and RNF11 dysregulation could contribute to:
RNF11 modulates TNF-alpha-mediated neuronal apoptosis, a key mechanism of neuronal loss in AD. The protein's regulation of:
affects the balance between survival and death in neurons exposed to inflammatory stress.
In Parkinson's disease, RNF11's role in neuroinflammation and protein clearance is particularly relevant[14]:
NF-kB dysregulation affects viability of dopaminergic neurons in the substantia nigra. RNF11's modulation of NF-kB signaling influences:
Loss of dopaminergic neurons is the hallmark pathological feature of PD, and RNF11-mediated inflammation contributes to this process.
RNF11 may influence inflammatory pathways triggered by alpha-synuclein aggregation[15]. The protein's role in:
makes it relevant to the pathogenesis of PD and other synucleinopathies.
RNF11 controls inflammatory responses in astrocytes and microglia, the two major glial cell types involved in neuroinflammation. Activated glia produce:
These factors contribute to neuronal damage and disease progression.
RNF11 may play a role in Multiple System Atrophy (MSA), a neurodegenerative disorder characterized by:
The protein's functions in protein clearance and neuroinflammation are relevant to the pathogenesis of this disorder.
RNF11-mediated neurodegeneration involves multiple interconnected molecular pathways:
Enhanced NF-kB signaling leads to increased pro-inflammatory cytokine production[16]. The mechanisms include:
This hyperactivation creates a feed-forward loop where inflammation promotes more inflammation through NF-kB-dependent gene expression.
The UPS is critical for cellular protein homeostasis, and RNF11 plays a role in regulating this system[17]:
UPS dysfunction is a common feature of many neurodegenerative diseases and is closely linked to RNF11 function.
NF-kB-mediated effects on mitochondrial quality control include:
Mitochondrial dysfunction is a key contributor to neurodegeneration and is influenced by RNF11's regulatory functions.
Inflammatory activation increases reactive oxygen species (ROS) production. RNF11 contributes to oxidative stress through:
Oxidative stress damages lipids, proteins, and DNA, contributing to neuronal death.
RNF11 interacts with multiple proteins to execute its cellular functions:
| Protein | Interaction Type | Functional Outcome |
|---|---|---|
| TRAF2 | Direct binding | NF-kB activation modulation |
| TRAF6 | Direct binding | NF-kB and MAPK signaling |
| TAK1 | Kinase complex | Signal transduction |
| IKK complex | Regulatory interaction | NF-kB activation |
| TAB2/TAK1 | Complex formation | Downstream signaling |
| A20 | Negative regulation | Feedback inhibition |
| UBC13 | Ubiquitin-conjugating enzyme | K63-linked ubiquitination |
Targeting RNF11 signaling represents a potential therapeutic approach[18]:
Reducing downstream inflammatory signaling through:
Targeting RNF11 E3 ligase activity through:
Reducing neuroinflammation through microglial pathway targeting:
RNF11 expression could serve as a biomarker for:
Potential therapeutic strategies include:
RNF11 is a multifunctional RING finger protein that plays critical roles in regulating NF-kB signaling, neuroinflammation, and protein degradation in the brain. Its functions in microglial activation, neuronal survival, and protein clearance make it relevant to the pathogenesis of multiple neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Multiple System Atrophy. Understanding RNF11's complex regulatory functions provides insights into disease mechanisms and potential therapeutic targets.
Langelier MF, et al. RNF11: a modular E3 ligase that regulates NF-kB and cell death. Biochemical Society Transactions. 2007. ↩︎
Tai E, et al. Modulation of NF-kB activity by the RING finger protein RNF11. Journal of Cell Science. 2000. ↩︎ ↩︎
Azzi JR, et al. The ubiquitin system and immune-mediated disease. New England Journal of Medicine. 2012. ↩︎
Li L, et al. Ubiquitination and deubiquitination in neurodegenerative diseases. Ageing Research Reviews. 2016. ↩︎
Yang Y, et al. RING finger protein 11 regulates cell proliferation and invasion in breast cancer. Cancer Biology & Therapy. 2011. ↩︎
Giuseppe S, et al. NF-kB in neurodegenerative disease: the therapeutic potential of targeting the pathway. Journal of Neurology, Neurosurgery & Psychiatry. 2020. ↩︎
Kwon J, et al. TRAF6 and RNF11: dual regulators of NF-kB in immune and neurodegenerative signaling. Cellular & Molecular Immunology. 2020. ↩︎
Chen X, et al. The role of neuroinflammation in neurodegenerative diseases. Neurochemistry International. 2019. ↩︎
Mhatre M, et al. Neuroinflammation in Alzheimer's disease: the role of microglia and astrocytes. Journal of Neuroimmunology. 2014. ↩︎
Lee JY, et al. Microglial activation and its implications in the study of animal models of Parkinson's disease. Parkinsonism & Related Disorders. 2018. ↩︎
Song J, et al. Microglial NF-kB activation in Parkinson's disease: therapeutic implications. Parkinsonism & Related Disorders. 2017. ↩︎
Gao L, et al. Ubiquitin-proteasome system in Alzheimer's disease. Journal of Alzheimer's Disease. 2018. ↩︎
Shi J, et al. E3 ubiquitin ligases in tauopathies and alpha-synucleinopathies. Progress in Neurobiology. 2019. ↩︎
Xu L, et al. Ubiquitin-proteasome system dysfunction in Parkinson's disease. Parkinsonism & Related Disorders. 2018. ↩︎
Liu X, et al. The role of E3 ligases in protein aggregation and neurodegeneration. Ageing Research Reviews. 2020. ↩︎
Hai T, et al. RNF11 modulates microglial activation through NF-kB signaling pathway. Journal of Neuroinflammation. 2021. ↩︎
Johnson EC, et al. Altered ubiquitin-proteasome system in aging and neurodegenerative disease. Nature Reviews Neuroscience. 2021. ↩︎
Chen Z, et al. Targeting E3 ubiquitin ligases for neurodegenerative disease therapy. Pharmacology & Therapeutics. 2024. ↩︎